ClinVar Miner

Submissions for variant NM_000245.4(MET):c.2996A>T (p.Glu999Val)

dbSNP: rs912927724
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV002234335 SCV000939059 uncertain significance Renal cell carcinoma 2018-12-01 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with MET-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with valine at codon 1017 of the MET protein (p.Glu1017Val). The glutamic acid residue is highly conserved and there is a moderate physicochemical difference between glutamic acid and valine.
Ambry Genetics RCV004944166 SCV005450765 uncertain significance Hereditary cancer-predisposing syndrome 2024-08-17 criteria provided, single submitter clinical testing The p.E1017V variant (also known as c.3050A>T), located in coding exon 13 of the MET gene, results from an A to T substitution at nucleotide position 3050. The glutamic acid at codon 1017 is replaced by valine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.